EUVIMEDOpdag EUVIMED
Crossref

Clots and bleeds: the outcomes of percutaneous coronary intervention in hemophilia patients with acute coronary syndrome

Michel Al Achkar iD, Georges Khattar iD, Samer Asmar, Michel El Khoury, Fares Saliba, Laurence Aoun, Ibrahim Al Saidi, Ghada Araji, Salman Khan, Elie Bou Sanayeh, Mitchell Weinberg, Alexander Bershadskiy

Catheterization and Cardiovascular Interventions · 2024-12 · 104 (7) · 1387-1395

DOI: 10.1002/ccd.31269 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, published online on 2024-10-17. Written by Michel Al Achkar and 11 co-authors. Institution: Department of Internal Medicine, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA. Major MEDLINE topics: Percutaneous Coronary Intervention, Hemophilia A, Acute Coronary Syndrome, Databases, Factual. Cited 1 times so far (Crossref); 29 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Hemophilia is a disease characterized by a high risk of bleeding. With advances in treatment, life expectancy and aging‐associated diseases such as coronary artery disease have increased. Our primary objective is to assess for major adverse outcomes, mortality, and length of hospital stay in individuals with hemophilia presenting for acute coronary syndrome (ACS) and undergoing percutaneous coronary intervention (PCI).

Methods

Our retrospective cohort study analyzed data from the Nationwide Inpatient Sample Database (NIS) for 2018 to investigate the outcomes of ACS management with PCI in adults with and without hemophilia. We used ICD‐10 codes to exclude patients with significant comorbidities and identify those with ACS undergoing PCI. Propensity score matching and multivariable logistic regression were employed to account for over 20 baseline characteristics, mitigating confounding factors.

Results

The incidence of gastrointestinal bleeding (11.0% vs. 2.8%, p < 0.001), hemorrhagic stroke (10.0% vs. 1.4%, p < 0.001), and retroperitoneal hemorrhage (5.6% vs. 1.4%, p < 0.001) was significantly higher in individuals with hemophilia undergoing PCI compared to those without hemophilia. Additionally, venous thromboembolism (VTE) incidence was notably higher in the hemophilia cohort (6.6% vs. 2.4%, p = 0.027). The hemophilia cohort also experienced a higher mortality rate (7.1% vs. 3.3%, p = 0.037) and longer hospital stays.

Conclusion

Patients with hemophilia undergoing PCI are at a significantly greater risk of adverse events, increased mortality, and longer hospital stays than the general population. To mitigate the risk of unfavorable outcomes, it is crucial to ensure adequate replenishment of coagulation factors and establish close collaboration between cardiologists and hematologists.

Subjects

MeSH terms (MEDLINE)

Percutaneous Coronary InterventionHemophilia AAcute Coronary SyndromeDatabases, FactualLength of StayHemorrhageHumansRetrospective StudiesMaleFemaleTreatment OutcomeRisk FactorsMiddle AgedUnited StatesRisk AssessmentAgedTime FactorsIncidenceCoronary ThrombosisAdult

Author keywords

acute coronary syndromegastrointestinal bleedinghemophiliaintracranial bleedingpercutaneous coronary interventionvenous thromboembolism

Authors and institutions

  • Department of Internal Medicine, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA.
  • Department of Cardiology, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA.
  • Department of Interventional Cardiology and Vascular Medicine, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA.
  • Chair of Cardiology, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA.
  • Departement of Hematology and Medical Oncology, Staten Island Univesity Hospital/Northwell Health, Staten Island, New York, USA.

ORCID profiles: Michel Al Achkar, Georges Khattar

Cite

APA

Achkar, M. A., Khattar, G., Asmar, S., El Khoury, M., Saliba, F., Aoun, L., Saidi, I. A., Araji, G., Khan, S., Sanayeh, E. B., Weinberg, M., & Bershadskiy, A. (2024). Clots and bleeds: the outcomes of percutaneous coronary intervention in hemophilia patients with acute coronary syndrome. Catheterization and Cardiovascular Interventions, 104(7), 1387-1395. https://doi.org/10.1002/ccd.31269

Vancouver

Achkar MA, Khattar G, Asmar S, El Khoury M, Saliba F, Aoun L, et al. Clots and bleeds: the outcomes of percutaneous coronary intervention in hemophilia patients with acute coronary syndrome. Catheterization and Cardiovascular Interventions. 2024;104(7):1387-1395. doi:10.1002/ccd.31269

BibTeX
@article{Achkar2024,
  author = {Achkar, Michel Al and Khattar, Georges and Asmar, Samer and El Khoury, Michel and Saliba, Fares and Aoun, Laurence and Saidi, Ibrahim Al and Araji, Ghada and Khan, Salman and Sanayeh, Elie Bou and Weinberg, Mitchell and Bershadskiy, Alexander},
  title = {Clots and bleeds: the outcomes of percutaneous coronary intervention in hemophilia patients with acute coronary syndrome},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  volume = {104},
  number = {7},
  pages = {1387--1395},
  doi = {10.1002/ccd.31269}
}
Start for free →